Compliance and yield of follow-up colonoscopy after a positive FIT in real-life practice: a university hospital experience
Authors:
Open Access
- 20 November 2025
- journal article
- research article
- Published by Springer Nature in BMC Gastroenterology
- Vol. 25 (1) , 826
Abstract
The fecal immunochemical test (FIT) is a diagnostic modality for colorectal cancer (CRC) screening, with the US Multisociety Task Force setting an 80% adherence benchmark for follow-up colonoscopy (FUC). Guidelines recommend that FITs be performed only in the context of CRC screening. Our study is a retrospective review of all patients with positive FIT records from 2018 to 2023. Patient characteristics, FIT ordering practices, and clinical settings were collected. The compliance rates with FUC, colonoscopy diagnostic yield, and adenoma detection were analyzed, and adherent and nonadherent patients were compared via univariate and logistic regression analyses. A total of 1424 patients had positive FIT results, with ages ranging between 18 and 92 years. Among the 1424 patients, 245 (17.2%) were < 45 years (group 1), 829 (52.9%) were 45–75 years (group 2), and 350 (24.6%) were > 75 years (group 3). In group 2, 241 (16.9%) tests were conducted for CRC screening. Seven hundred and three (49.3%) positive FIT tests, including tests for abdominal pain and anemia, were carried out for diagnostic purposes. Only 618 (43.3%) patients with positive FIT results underwent FUC, of whom 277 (44.8%) had adenomas and 28 (4.5%) were diagnosed with CRC. Bivariate analysis revealed that age, fewer comorbidities, prior colonoscopy, family history of CRC, diagnostic FIT, and outpatient setting increased FUC adherence. Multivariate analysis revealed that age and outpatient setting were predictive factors. Although FITs are used for CRC screening, our study found a discrepancy between guidelines and real-world practice. Compliance with FUC after a positive FIT is below the optimal range, with adherence decreasing with age.Keywords
This publication has 16 references indexed in Scilit:
- Feasibility and Colonoscopy Yield Using the Fecal Immunochemical Test (FIT)-Based Colorectal Cancer Screening in a Latin America CountryClinical Gastroenterology and Hepatology, 2024
- Rates of Follow-up Colonoscopy After a Positive Stool-Based Screening Test Result for Colorectal Cancer Among Health Care Organizations in the US, 2017-2020JAMA Network Open, 2023
- Pooled rates of adenoma detection by colonoscopy in asymptomatic average-risk individuals with positive fecal immunochemical test: a systematic review and meta-analysisGastrointestinal Endoscopy, 2022
- Barriers to Follow-up Colonoscopies for Patients With Positive Results From Fecal Immunochemical Tests During Colorectal Cancer ScreeningClinical Gastroenterology and Hepatology, 2019
- Performance of colorectal cancer screening in the European Union Member States: data from the second European screening reportGut, 2018
- Yield of Colonoscopy After a Positive Result From a Fecal Immunochemical Test OC-LightClinical Gastroenterology and Hepatology, 2018
- Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at DiagnosisJAMA, 2017
- Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening TestClinical Gastroenterology and Hepatology, 2016
- Inappropriate use of the faecal occult blood test in a university hospital in the NetherlandsEuropean Journal of Gastroenterology & Hepatology, 2012
- Patients’ experiences and reported barriers to colonoscopy in the screening context—A systematic review of the literaturePatient Education and Counseling, 2012